L B Conanan

466 total citations
14 papers, 381 citations indexed

About

L B Conanan is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Pharmacology. According to data from OpenAlex, L B Conanan has authored 14 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Cancer Research and 4 papers in Pharmacology. Recurrent topics in L B Conanan's work include Protease and Inhibitor Mechanisms (5 papers), Clinical Nutrition and Gastroenterology (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). L B Conanan is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Clinical Nutrition and Gastroenterology (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). L B Conanan collaborates with scholars based in United States and Brazil. L B Conanan's co-authors include David J. Crutchley, James R. Maynard, Benito G. Que, Seigo Nishida, Violet Esquenazi, Jang Moon, Andreas G. Tzakis, Debbie Weppler, David Levi and Gennaro Selvaggi and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

L B Conanan

14 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L B Conanan United States	11	130	113	83	71	66	14	381
Kjell Sverre Galdal Norway	11	76 0.6×	218 1.9×	35 0.4×	59 0.8×	97 1.5×	14	462
Toshi Yoneda Japan	7	180 1.4×	23 0.2×	49 0.6×	91 1.3×	257 3.9×	10	608
L.G.M. Huisman Netherlands	10	111 0.9×	96 0.8×	9 0.1×	35 0.5×	141 2.1×	18	454
Margaret L. Snyder United States	11	197 1.5×	25 0.2×	24 0.3×	289 4.1×	141 2.1×	16	602
Diane M. Pierson United States	9	21 0.2×	32 0.3×	61 0.7×	37 0.5×	111 1.7×	11	324
Sudipta Biswas United States	10	64 0.5×	51 0.5×	20 0.2×	41 0.6×	155 2.3×	12	364
Dong‐Chen Shieh Taiwan	8	54 0.4×	20 0.2×	17 0.2×	44 0.6×	107 1.6×	13	421
Yuji Matsuzawa Japan	11	71 0.5×	21 0.2×	18 0.2×	150 2.1×	259 3.9×	17	499
David H. McMillan United States	8	74 0.6×	44 0.4×	14 0.2×	15 0.2×	149 2.3×	11	339
John V. Mitsios Greece	13	55 0.4×	99 0.9×	10 0.1×	202 2.8×	107 1.6×	21	474

Countries citing papers authored by L B Conanan

Since Specialization

Citations

This map shows the geographic impact of L B Conanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L B Conanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L B Conanan more than expected).

Fields of papers citing papers by L B Conanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L B Conanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L B Conanan. The network helps show where L B Conanan may publish in the future.

Co-authorship network of co-authors of L B Conanan

This figure shows the co-authorship network connecting the top 25 collaborators of L B Conanan. A scholar is included among the top collaborators of L B Conanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L B Conanan. L B Conanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

David, André Ibrahim, Jeffrey J. Gaynor, Phillip Ruiz, et al.. (2008). Valor crítico da citrulina para as complicações do enxerto no transplante de intestino. Revista da Associação Médica Brasileira. 54(5). 426–9. 3 indexed citations

David, André Ibrahim, Gennaro Selvaggi, Phillip Ruiz, et al.. (2007). Blood Citrulline Level Is an Exclusionary Marker for Significant Acute Rejection After Intestinal Transplantation. Transplantation. 84(9). 1077–1081. 44 indexed citations

David, André Ibrahim, Jeffrey J. Gaynor, Panagiotis Zis, et al.. (2006). An Association of Lower Serum Citrulline Levels Within 30 Days of Acute Rejection in Patients Following Small Intestine Transplantation. Transplantation Proceedings. 38(6). 1731–1732. 18 indexed citations

Yu, Hee Chul, Sony Tuteja, Jang Moon, et al.. (2005). Utilization of Dried Blood Spot Citrulline Level as a Noninvasive Method for Monitoring Graft Function Following Intestinal Transplantation. Transplantation. 80(12). 1729–1733. 34 indexed citations

Crutchley, David J., L B Conanan, & Benito G. Que. (1995). K ⁺ Channel Blockers Inhibit Tissue Factor Expression by Human Monocytic Cells. Circulation Research. 76(1). 16–20. 10 indexed citations

Crutchley, David J., L B Conanan, & Benito G. Que. (1994). Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.. Journal of Pharmacology and Experimental Therapeutics. 271(1). 446–451. 30 indexed citations

Crutchley, David J., et al.. (1993). Effects of prostacyclin analogues on human endothelial cell tissue factor expression.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(7). 1082–1089. 14 indexed citations

Crutchley, David J., et al.. (1992). Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 12(6). 664–670. 20 indexed citations

Crutchley, David J., L B Conanan, & Una Ryan. (1987). Endotoxin-induced secretion of an active plasminogen activator inhibitor from bovine pulmonary arterial and aortic endothelial cells. Biochemical and Biophysical Research Communications. 148(3). 1346–1353. 4 indexed citations

10.

Crutchley, David J. & L B Conanan. (1986). Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.. Journal of Biological Chemistry. 261(1). 154–159. 69 indexed citations

11.

Conanan, L B, et al.. (1983). Serum-dependent induction of plasminogen activator in human fibroblasts by catecholamines and comparison with the effects of prostaglandins E1. Biochimica et Biophysica Acta (BBA) - General Subjects. 759(3). 146–153. 5 indexed citations

12.

Crutchley, David J., L B Conanan, & James R. Maynard. (1982). Stimulation of fibrinolytic activity in human skin fibroblasts by prostaglandins E1, E2 and I2.. Journal of Pharmacology and Experimental Therapeutics. 222(3). 544–549. 52 indexed citations

13.

Crutchley, David J., L B Conanan, & James R. Maynard. (1981). HUMAN FIBROBLASTS PRODUCE INHIBITOR DIRECTED AGAINST PLASMINOGEN ACTIVATOR WHEN TREATED WITH GLUCOCORTICOIDS*. Annals of the New York Academy of Sciences. 370(1). 609–616. 55 indexed citations

14.

Crutchley, David J., L B Conanan, & James R. Maynard. (1980). Induction of plasminogen activator and prostaglandin biosynthesis in HeLa cells by 12-O-tetradecanoylphorbol-13-acetate.. PubMed. 40(3). 849–52. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact